Pharming Group N.V. - Laporan Laba Rugi (TTM)

Pharming Group N.V.
NL ˙ ENXTAM ˙ NL0010391025
€ 1.28 ↑0.01 (1.02%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pharming Group N.V. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 180 212 172 200 173 199 202 202 204 206 202 206 219 245 258 278 286 297 321 340
Change (%) 17.63 -18.73 16.19 -13.70 15.01 1.54 0.23 0.68 0.91 -1.98 2.36 6.02 12.16 5.32 7.43 2.95 4.01 7.91 5.96
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 20 24 19 21 30 21 21 21 4 18 17 18 24 25 30 32 30 35 35 36
Change (%) 19.06 -18.36 11.03 39.57 -29.01 0.16 -2.90 -81.40 359.14 -4.57 10.11 32.04 3.46 17.10 7.64 -4.64 16.81 -0.18 2.80
% of Revenue 10.96 11.09 11.14 10.65 17.22 10.63 10.49 10.16 1.88 8.54 8.32 8.95 11.14 10.28 11.43 11.45 10.61 11.91 11.02 10.69
Gross Operating Profit 161 189 153 179 143 178 181 182 200 188 185 188 194 220 229 246 255 262 285 304
Change (%) 17.45 -18.77 16.84 -20.05 24.17 1.70 0.60 9.96 -5.94 -1.74 1.65 3.47 13.25 3.97 7.40 3.93 2.49 9.00 6.36
% of Revenue 89.04 88.91 88.86 89.35 82.78 89.37 89.51 89.84 98.12 91.46 91.68 91.05 88.86 89.72 88.57 88.55 89.39 88.09 88.98 89.31
SG&A 64 76 68 83 76 91 94 100 110 127 140 157 160 175 184 187 195 184 190 199
Change (%) 18.92 -10.48 22.18 -8.36 19.91 3.22 6.60 9.74 16.02 9.54 12.14 2.31 9.43 4.71 1.99 4.26 -5.49 3.26 4.57
% of Revenue 35.29 35.67 39.29 41.32 43.88 45.74 46.50 49.46 53.91 61.98 69.27 75.89 73.23 71.44 71.03 67.44 68.29 62.05 59.38 58.60
R&D 28 39 35 44 41 65 70 70 69 53 53 60 68 69 72 72 72 83 84 88
Change (%) 38.96 -10.31 26.68 -5.71 58.43 6.37 1.33 -1.46 -24.35 1.44 12.16 14.07 0.71 4.23 0.95 -0.04 15.14 0.63 5.02
% of Revenue 15.37 18.15 20.03 21.84 23.87 32.87 34.44 34.82 34.08 25.55 26.44 28.97 31.17 27.99 27.70 26.03 25.27 27.98 26.09 25.86
OpEx 110 136 120 145 145 175 181 188 167 195 208 233 243 267 283 289 295 301 307 320
Change (%) 23.25 -11.75 21.11 -0.52 21.00 3.72 3.43 -11.15 17.13 6.36 12.35 4.25 9.80 5.88 2.31 2.06 1.87 2.14 4.22
% of Revenue 61.14 64.06 69.56 72.50 83.58 87.93 89.83 92.69 81.80 94.96 103.04 113.10 111.20 108.87 109.44 104.23 103.33 101.21 95.80 94.22
Operating Income 70 76 52 55 28 24 21 15 37 10 -6 -27 -24 -22 -24 -12 -10 -4 13 20
Change (%) 8.78 -31.16 4.97 -48.47 -15.47 -14.41 -28.02 150.76 -72.04 -159.04 341.35 -9.31 -11.22 12.18 -51.89 -18.91 -62.24 -474.90 45.79
% of Revenue 38.86 35.94 30.44 27.50 16.42 12.07 10.17 7.31 18.20 5.04 -3.04 -13.10 -11.20 -8.87 -9.44 -4.23 -3.33 -1.21 4.20 5.78
Interest Expense -11 -6 -6 -6 -6 -6 -5 -7 -6 -6 -6 -5 -7 -9 -9 -12 -10
Change (%) -47.88 -3.60 -3.37 -1.25 -4.37 26.43 -17.36 7.20 -0.62 -20.77 38.10 35.34 -1.06 40.54 -16.04
% of Revenue -6.32 -2.80 -3.06 -2.91 -2.80 -2.75 -2.61 -3.36 -2.71 -2.74 -2.43 -1.83 -2.35 -3.09 -2.94 -3.83 -3.03
Net Income 38 38 32 31 19 16 11 21 30 14 -2 -16 -22 -11 -11 -13 -18 -12 -14 -8
Change (%) 0.03 -16.13 -3.39 -37.66 -16.10 -31.65 90.66 45.67 -54.97 -114.59 722.96 34.33 -52.17 2.28 23.52 33.76 -33.56 19.18 -41.89
% of Revenue 20.92 17.79 18.36 15.27 11.03 8.04 5.41 10.30 14.90 6.65 -0.99 -7.96 -10.08 -4.30 -4.18 -4.80 -6.24 -3.98 -4.40 -2.41

Source: Capital IQ

Other Listings
GB:0QCO € 1.28
DE:PHGN € 1.28
US:PHGUF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista